3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Rectal Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Myocarditis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Extranodal NK-T-Cell
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma in Situ
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
5
Rituximab
4
Vincristine
3
Prednisone
3
Doxorubicin
3
Etoposide
2
venetoclax
1
pembrolizumab
1
liposomal doxorubicin
1
ibrutinib
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
acalabrutinib
1
Zidovudine
1
Whole-Body Irradiation
1
Valganciclovir
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Nivolumab
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Interferon-alpha
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
CLR1404
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Tomography, X-Ray Computed
×
90 days
×
Clear all
No trials found.